Toxicological and Pharmacokinetic Properties of QPI-1007, a Chemically Modified Synthetic siRNA Targeting Caspase 2 mRNA, Following Intravitreal Injection
Year: 2014
Type: article
Source: Nucleic Acid Therapeutics
Authors: Elisabeth C.R. Solano, Douglas J. Kornbrust, Amber Beaudry, Jeffrey W.-D. Foy, David J. Schneider, James D. Thompson
Institution: Quark Pharmaceuticals (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W142058135
